Blatant antisemitic motives by BNP Paribas claimed by Jacob Agam in €1 Billion lawsuit filed by Farrugia, Gatt & Falzon


LONDON, March 06, 2019 (GLOBE NEWSWIRE) -- French bank BNP Paribas, its Chairman Jean Lemierre, CEO Jean Laurent Bonnafé and the bank’s legal representative Valérie Lafarge-Sarkozy are the subjects of a lawsuit filed on behalf of Jacob Agam and Vertical Group Holding Ltd by Farrugia, Gatt & Falzon in Malta on 1st March 2019 with a claim for damages estimated to reach €1 billion. The bank and the other Respondents are specifically accused in the Claim filed, of having conducted an alleged smear campaign against the plaintiffs Jacob Agam and his company Vertical Group, violating amongst others, statutory banking and defamation laws. The bank and other Respondents are accused of spreading damaging statements to the world’s media, falsely claiming in 2017 that the Plaintiffs “wriggled out” of financial obligations, which, according to the claim, never occurred. The bank’s alleged smear campaign, it is claimed, has destroyed the Plaintiffs’ pending transactions, professional reputation and credit standing, resulting in severe loss of business and the termination of transactions causing direct losses and damages estimated to reach €1 billion.

The bank’s actions, the Plaintiffs claim, were a part of a long-running dispute between the parties after Mr Agam persistently challenged the bank over its admission of and criminal conviction for its alleged antisemitic stance, as well as having conducted financial transactions with terrorist organisations acting against the State of Israel. The Plaintiffs are the Malta-based Vertical Group Holding Limited and its chairman and founder Jacob Agam, with whom BNP Paribas still maintains a client relationship, with all the banking responsibilities attached. According to the claim, the Plaintiffs have honoured all of their obligations as clients of the bank.

According to the claim filed, in 2014, following Mr Agam’s challenges regarding its antisemitic actions and financial transactions with terrorist organisations, and with the subsequent support of European and Israeli parliamentarians, as well as having highlighted the bank’s $40 million settlement with a former employee who was subjected to viewing imagery of Hitler in a positive context as part of an internal training video produced by the bank’s management in Europe, the bank responded with the abrupt termination of his companies’ investment facilities. The claim states that despite the bank’s apparent breaches, those facilities were fully honoured and paid by the Plaintiffs, with the bank’s acknowledgement.

The claim states that the bank’s representative, Ms Lafarge-Sarkozy, then sought to seize Mr Agam’s and his sister’s properties, stating in front of several witnesses during an open court hearing in late 2016 that she regards Jews as “ces gens-là”, or “these people”, a highly derogatory antisemitic phrase in the French language, which, according to her, defines Jewish people as “p arasites lounging around in luxurious estates living at the expense of the bank and a part of an international financial world”, echoing a dark chapter in history.

According to the lawsuit filed, Mr Agam claims that when he continued his challenge of the bank’s antisemitic actions, the bank unexpectedly chose, in late 2016, to engage a Jewish lawyer Jean Veil, from a known family of Holocaust survivors, who was instructed to solicit a written apology from Mr Agam for having challenged the bank over its pattern of antisemitic behaviour as a condition of reaching a settlement, or else the bank would exercise its power against him.

The bank’s CEO and Chairman, despite their knowledge of the case and multiple requests for their respective intervention, failed to act to, either condemn or prevent the alleged destructive smear campaign against the Plaintiffs and their respective assets and businesses, which led to a direct loss and damages estimated to reach €1 billion or more.

Jacob Agam commented: “As demonstrated in the past, the Respondents failed to see themselves accountable to the rule of law. The bank’s management must not and cannot hide behind its corporate veil to solicit and/or to condone all forms of racism. With its current misconduct, I fear a repeat of the bank’s past admissions, reaching new heights. I trust all relevant stakeholders, in particular the bank’s shareholders, will intervene to put a stop to the repeated misconducts by the bank and its management, which have been committed at the expense of the bank’s shareholders and clients.”

Dr. Pio M. Valletta of Maltese law firm Farrugia, Gatt & Falzon, who filed the lawsuit on behalf of Mr Agam and his company Vertical Group Holding Limited, commented: “BNP Paribas has long been accused of a systematic pattern of antisemitism. In my long professional career, the behaviour of BNP Paribas against my client Mr. Jacob Agam, his family and his assets including Vertical Group Holding Limited, stands out as amongst the most destructive behaviour by a bank against its clients, with ample evidences to be presented to the court as to the bank’s racial motives.”

A photo accompanying this announcement is available at

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

AMG Advanced Metallurgical Group N.V. Announces Weekly Share Repurchase Program Transaction Details19.7.2019 21:00:00 CESTPress release

Amsterdam, 19 July 2019 --- AMG Advanced Metallurgical Group N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") reports the repurchases made under its share repurchase program announced on 8 April 2019 and effective from 9 April 2019. Information regarding the progress of the share repurchase program and the aggregate of the transactions (calculated on a daily basis) for the period 15 July 2019 through 19 July 2019 can be found in the bottom half of the table below. Further detailed information regarding both the progress of the share repurchase program and the overall trades made on a daily basis can be accessed via the Investors section of the Company’s website, or clicking the following link: Share Repurchase Program Overall progress Share Repurchase Program: Total Repurchase Amount in Shares 2,915,630 Cumulative Repurchase Amount EUR 63,511,098 Cumulative Quantity Repurchased 2,534,054 Cumulative Average Repurchase Price EUR 25.06 Start Date 9 April

Ossur Hf : Össur acquires College Park Industries19.7.2019 17:00:00 CESTPress release

Reykjavik, 19 July 2019 Össur has signed an agreement to acquire College Park Industries, a global provider of lower and upper limb prostheses and supporting services. College Park has over 140 employees and is headquartered in Detroit, USA. Total sales amounted to USD 22 million in 2018. College Park will largely remain independent and continue to diligently serve its customer base, while allowing the combined entity to achieve strategic efficiencies. Össur is committed to growing the College Park brand over the coming years both in the United States and international markets. Together, both companies will be well-positioned to enhance their offerings in both lower and upper limb prosthetics. With this acquisition, Össur hopes to support College Park’s focus on the lower active population and further strengthen its established presence in the upper limb arena. Mutual access to technology and products will enable a more comprehensive product and service offering to customers around the

Norsk Hydro: PÅMINNELSE: Invitasjon - Presentasjon av Hydros resultat for andre kvartal 201919.7.2019 14:43:00 CESTPressemelding

Hydros resultat for andre kvartal 2019 blir offentliggjort tirsdag 23. juli 2019 kl. 07.00. Kvartalsrapporten og presentasjonsmaterialet blir samtidig gjort tilgjengelig på Presentasjon i Oslo Det blir holdt en kombinert analytikerpresentasjon og pressekonferanse ved Hydros hovedkontor i Drammensveien 260, Oslo, samme dag, kl. 08.30. Resultatet blir presentert av konsernsjef Hilde Merete Aasheim og konserndirektør for Økonomi og finans Eivind Kallevik. Hele presentasjonen kan sees direkte på web-TV. For påmelding, vennligst send mail til I tillegg til web-TV, hvor det vil være mulig å stille spørsmål skriftlig, vil det også være mulig å ringe inn (ikke mulig å stille spørsmål over telefon). Du melder deg på denne telefonkonferansen ved å ringe: Norge +47 2100 2610 UK +44 (0)330 336 9125 USA +1 929-477-0324 Sverige +46 (0)8 5033 6574 Brasil +55 11 3181 5427 Tyskland +49 (0)89 20303 5709 Kode: 3104804 Q&A / Telefonkonferanse Det blir holdt en telefonkonferans

Norsk Hydro: REMINDER: Invitation - Hydro’s second quarter results 201919.7.2019 14:43:00 CESTPress release

Hydro's second quarter results 2019 will be released at 07:00 CEST (01:00 AM EDT, 06:00 UK time), on Tuesday July 23, 2019. The quarterly report and presentation slides will be available on at the same time. Presentation in Oslo Hydro will host a combined analyst and press conference, in English, at its corporate headquarters at Drammensveien 260, Oslo, at 08:30 CEST the same day. The presentation will be held by President and CEO Hilde Merete Aasheim and CFO Eivind Kallevik and can also be seen on web TV. To attend the presentation in Oslo, please register by sending a mail to In addition to the webcast, where it will be possible to ask questions in writing, it will also be possible to dial in (not possible to ask questions over the phone). Dial-in numbers for this conference call are: Norway +47 2100 2610 UK +44 (0)330 336 9125 USA +1 929-477-0324 Sweden +46 (0)8 5033 6574 Brazil +55 11 3181 5427 Germany +49 (0)89 20303 5709 Confirmation Code: 3104804 Q&A

Sunstone Life Science Ventures invests in Karolinska Development's portfolio company Forendo Pharma19.7.2019 14:00:00 CESTPressemelding

STOCKHOLM – July 19, 2019. Karolinska Development's portfolio company Forendo Pharma announces today that Sunstone Life Science Ventures joins the existing international investor syndicate and has made a EUR 5 million investment in Forendo Pharma. Claus Andersson, General Partner from Sunstone, joins Forendo Pharma’s Board of Directors. With the investment, Sunstone joins the existing international investor syndicate comprising Novo Seeds, Karolinska Development, Innovestor, Novartis Venture Fund, M Ventures and Vesalius Biocapital Partners. The new financing will enable Forendo Pharma to progress its lead endometriosis program, FOR-6219, an HSD17B1 enzyme inhibitor, into the next phase of clinical studies after the successful completion of its Phase 1a study earlier this year. Endometriosis is a chronic condition that affects many women of reproductive age and causes repeated pain symptoms, infertility and impaired quality of life. Currently available treatments for endometriosis have